Spécialité pharmaceutique à base d'immunoglobulines issues du plasma humain à administration IV
A newer notice was published for the same procedure. (update-add) TED 797524-2026, 17 Nov 2026. Dates and conditions of the latest notice prevail.
- Buyer
- Healthcare Public Procurement (HeCaPP), Saint-Gilles\Sint-Gillis
- Country
- Belgium
- Published
- 14 Oct 2026
- Deadline
- 16 Nov 2026 (earliest lot deadline; time and time zone in the official notice)
- Procedure
- open
- Contract nature
- supplies
- Place of performance (NUTS)
- BE100, BEL
- CPV
- 33600000 (Medical equipment and pharmaceuticals)
Procedure history
- TED 709064-2026 (this notice) · 14 Oct 2026 · cn-standard · Deadline 16 Nov 2026
- TED 797524-2026 · 17 Nov 2026 · cn-standard · update-add · Deadline 23 Nov 2026
Notices linked by their TED procedure identifier.
Description (original language)
Spécialité pharmaceutique à base d'immunoglobulines issues du plasma humain à administration IV
Notices can be corrected or cancelled by the buyer. The official notice on TED always prevails.
Source: TED, Publications Office of the EURetrieved: